Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Solventum: Q4 EPS Beats, Cash Flow Dips


Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at $1.41 against an anticipated $1.31 and revenue of $2.074 billion exceeded the expected $2.050 billion. Despite this, its adjusted free cash flow fell significantly to $92 million from $459 million year over year.

The overall quarterly performance was resilient against a backdrop of regulatory challenges and increased costs.

Source: Solventum. Note: Analyst consensus estimates for the quarter provided by FactSet. YOY = Year over year.

Continue reading


Source Fool.com

Like: 0
Share

Comments